Musculoskeletal · PANCE / PANRE

Systemic Lupus Erythematosus (SLE)

Written & clinically reviewed by Ryan Busch, PA-C · Updated August 2026 · Report an error

Multisystem autoimmune disease with autoantibodies against nuclear antigens and immune-complex tissue injury.

Also known as: SLE, lupus, systemic lupus

Overview

Chronic relapsing-remitting autoimmune disease characterized by loss of tolerance to nuclear self-antigens, production of autoantibodies (notably ANA, anti-dsDNA, anti-Smith), and immune-complex deposition that drives inflammation across skin, joints, kidneys, blood, serosa, and the central nervous system.

Epidemiology

Female-to-male ratio ~9:1; peak onset 15-44 years. More common and more severe in Black, Hispanic, and Asian populations. Lupus nephritis is the strongest predictor of morbidity.

Try two board-style Systemic Lupus Erythematosus questions

Real questions from the FirstPassPA bank, with the full explanation. Pick an answer — no signup, no email.

Question 1MusculoskeletalMedium
A 28-year-old woman has fatigue, a malar rash, photosensitivity, oral ulcers, pleuritic chest pain, and 2+ proteinuria. Antinuclear antibody (ANA) titer is 1:640. Which of the following additional antibodies is most specific for her diagnosis?
  • AAnti-Jo-1
  • BAnti-Ro/SSA
  • CAnti-Smith
  • DAnti-centromere
Reveal answer & full explanation
Correct answer: C — Anti-Smith
  • AAnti-Jo-1
  • BAnti-Ro/SSA
  • CAnti-Smith✓
  • DAnti-centromere

Why Anti-Smith is correct

  • The malar rash, photosensitivity, oral ulcers, serositis (pleuritic chest pain), and proteinuria with a high-titer ANA point to systemic lupus erythematosus (SLE).
  • Anti-Smith antibody has roughly 99% specificity for SLE, making it the most specific of the listed antibodies, although its sensitivity is only about 30%.
  • Anti-double-stranded DNA is also highly specific and additionally tracks disease activity and lupus nephritis.

Why the others are wrong

  • Anti-Jo-1 — marks antisynthetase syndrome (polymyositis with interstitial lung disease), not SLE; a buzzword-matching trap for myositis.
  • Anti-Ro/SSA — seen in Sjogren syndrome and neonatal lupus and is not specific for SLE, so it cannot confirm the diagnosis (confused-with sensitive-but-nonspecific marker).
  • Anti-centromere — associated with limited cutaneous systemic sclerosis (CREST), not SLE (premature closure on another connective-tissue disease).
Question 2MusculoskeletalMedium
A 31-year-old woman has photosensitive rash, oral ulcers, arthritis, and proteinuria. Which of the following tests is most specific for the suspected disease?
  • AAntinuclear antibody titer level
  • BAnti-Ro (SSA) antibody panel
  • CAnti-double-stranded DNA antibody
  • DRheumatoid factor antibody level
Reveal answer & full explanation
Correct answer: C — Anti-double-stranded DNA antibody
  • AAntinuclear antibody titer level
  • BAnti-Ro (SSA) antibody panel
  • CAnti-double-stranded DNA antibody✓
  • DRheumatoid factor antibody level

Why Anti-double-stranded DNA antibody is correct

  • Photosensitivity, oral ulcers, arthritis, and proteinuria fit systemic lupus erythematosus.
  • Anti-dsDNA is highly specific for SLE and titers track lupus nephritis activity.
  • It is the antibody used to confirm SLE once a positive ANA raises suspicion.

Why the others are wrong

  • Antinuclear antibody titer level — ANA is the screening test: nearly always positive in SLE but also positive in many non-lupus conditions, so it is sensitive, not specific (sensitivity-for-specificity trap).
  • Anti-Ro (SSA) antibody panel — Anti-Ro occurs in SLE but is more characteristic of Sjögren syndrome and subacute cutaneous/neonatal lupus, so it is not the most specific marker for SLE itself.
  • Rheumatoid factor antibody level — RF is nonspecific and points toward rheumatoid arthritis; it would not confirm a photosensitive, renal autoimmune disease (joint-overlap anchoring trap).
🔒 Free preview limit reached

Keep reading — start your free trial

You've read your 2 free diagnosis previews. Create your free account to unlock the full Systemic Lupus Erythematosus (SLE) outline — plus all 514 diagnoses, 6,500+ board-style questions, flashcards, and an AI tutor. Your 7-day free trial includes everything, and there's no credit card required.

Start your 7-day free trial → Sign in
Free to start · No credit card · Cancel anytime

Risk factors

  • Female sex, reproductive age
  • Black, Hispanic, Asian ancestry
  • Family history of SLE or other autoimmune disease
  • Environmental triggers: UV light, smoking, EBV exposure, silica
  • Hormonal: estrogens, oral contraceptives
  • Drug-induced lupus triggers (hydralazine, procainamide, isoniazid, minocycline, anti-TNF agents)

Pathophysiology

Defective clearance of apoptotic debris exposes nuclear antigens that bind self-reactive B and T cells. Autoantibodies form immune complexes that deposit in glomeruli, skin, and serosa, activating complement (low C3, C4) and recruiting neutrophils. Tissue injury results from immune-complex deposition, type I interferon overactivation, and direct cytotoxic mechanisms.

Clinical presentation

Symptoms

  • Constitutional: fatigue, low-grade fever, weight loss
  • Mucocutaneous: malar (butterfly) rash sparing nasolabial folds, discoid lesions, photosensitivity, oral or nasal ulcers (often painless), nonscarring alopecia
  • Musculoskeletal: symmetric small-joint polyarthralgia/arthritis, typically nonerosive (Jaccoud arthropathy if deforming)
  • Serositis: pleuritic chest pain, pericardial pain
  • Renal: foamy urine, edema (lupus nephritis)
  • Neuropsychiatric: headache, seizures, psychosis, cognitive dysfunction, stroke
  • Hematologic: easy bruising, recurrent infection (cytopenias)
  • Raynaud phenomenon

Signs / physical exam

  • Malar rash, discoid plaques, oral ulcers
  • Synovitis of MCPs, PIPs, wrists, knees
  • Pleural or pericardial friction rub
  • Hypertension and peripheral edema (nephritis)
  • Livedo reticularis (consider APS)

Differential diagnosis

  • Drug-induced lupus — Hydralazine, procainamide, isoniazid, minocycline, anti-TNFs; anti-histone antibodies positive; renal and CNS involvement rare; resolves on withdrawal
  • Rheumatoid arthritis — Erosive symmetric polyarthritis; RF/anti-CCP positive; rarely causes renal disease or photosensitive rash
  • Mixed connective tissue disease — Overlap of SLE, scleroderma, polymyositis; high-titer anti-U1 RNP
  • Antiphospholipid syndrome — Arterial/venous thrombosis, pregnancy loss; lupus anticoagulant, anti-cardiolipin, anti-beta2 GP1; can coexist with SLE
  • Fibromyalgia — Diffuse pain without inflammation; normal labs; often coexists with SLE and confounds disease activity assessment
  • Viral arthritis (parvovirus B19, hepatitis C) — Self-limited polyarthritis ± rash; serologies and time course distinguish
  • Behcet disease — Oral and genital aphthae, uveitis, pathergy; ANA negative

Diagnostic workup

Diagnostic criteria

EULAR/ACR 2019 classification criteria: ANA ≥1:80 as entry, then weighted clinical and immunologic domains (total ≥10 points classifies).

Labs

  • ANA — screening test; sensitivity >95% but low specificity
  • Anti-dsDNA — specific; titer correlates with disease activity (especially nephritis)
  • Anti-Smith — highly specific
  • Anti-Ro/SSA, anti-La/SSB (sicca features, neonatal lupus, subacute cutaneous lupus)
  • Anti-U1 RNP (mixed connective tissue disease overlap)
  • Antiphospholipid antibodies — lupus anticoagulant, anti-cardiolipin, anti-beta2 GP1
  • Complement C3, C4 — low during active disease
  • CBC (cytopenias), Coombs test if hemolysis
  • Urinalysis with sediment, urine protein-to-creatinine ratio, BMP
  • ESR elevated; CRP often normal-to-mildly elevated (use to flag infection)

Imaging

  • Renal biopsy — definitive for lupus nephritis classification (ISN/RPS classes I-VI); guides immunosuppression
  • Echo if pericardial effusion or Libman-Sacks endocarditis suspected
  • MRI brain for neuropsychiatric SLE workup

Diagnostic algorithm

AutoantibodyClinical Association
ANASensitive screen (>95%); not specific
Anti-dsDNASpecific; tracks nephritis activity
Anti-SmithHighly specific for SLE
Anti-Ro/SSA, anti-La/SSBSicca, subacute cutaneous lupus, neonatal lupus (congenital heart block)
Anti-U1 RNPMixed connective tissue disease overlap
Antiphospholipid (LAC, aCL, anti-beta2 GP1)Thrombosis, pregnancy loss
Anti-histoneDrug-induced lupus
Low C3 / C4Active disease, especially nephritis
Lupus autoantibody profile — high-yield clinical associations.

Treatment

First-line

  • Sun protection and smoking cessation for all patients
  • Hydroxychloroquine 200-400 mg/day — foundational for all SLE; reduces flares, organ damage, and mortality (baseline eye exam, annually after 5 years)
  • NSAIDs — ibuprofen, naproxen — for mild musculoskeletal or serositis symptoms (caution with renal disease)
  • Low-dose glucocorticoids — prednisone ≤7.5 mg/day for ongoing activity; higher doses or pulse methylprednisolone for major organ flares

Complications

  • Lupus nephritis → ESRD
  • Accelerated atherosclerosis (premature CAD, stroke)
  • Antiphospholipid syndrome — thrombosis, recurrent miscarriage
  • Libman-Sacks endocarditis (sterile valvular vegetations)
  • Avascular necrosis (often femoral head — steroid-related)
  • Infection (immunosuppression-related, leading cause of death)
  • Pregnancy complications: preeclampsia, fetal loss, neonatal lupus (anti-Ro/SSA → congenital heart block)

PANCE pearls

  • ANA-negative SLE is rare; if ANA is negative, the diagnosis becomes very unlikely.
  • Anti-dsDNA titer and complement levels often track with disease activity — particularly useful in lupus nephritis follow-up.
  • CRP normal in active SLE; elevated CRP should raise concern for infection or serositis.
  • Hydroxychloroquine retinopathy risk rises after 5 years; screen at baseline and annually thereafter (especially with renal impairment or tamoxifen).
  • Avoid sulfa antibiotics — may precipitate flares.

References

  • EULAR/ACR 2019 — 2019 EULAR/ACR Classification Criteria for SLE (Aringer et al., Ann Rheum Dis 2019)
  • EULAR 2023 — EULAR Recommendations for the Management of SLE (Fanouriakis et al., Ann Rheum Dis 2024)
  • ACR 2012 — ACR Guidelines for Screening, Treatment, and Management of Lupus Nephritis (Hahn et al., Arthritis Care Res 2012)

Practice Musculoskeletal questions on FirstPassPA

Turn this outline into retention. 6,500+ board-style questions with an AI tutor that explains every answer — free to start, no card required.

Answer the 2 free questions above → Get today's free question →

Commonly confused with

vs Rheumatoid Arthritis

Related Musculoskeletal diagnoses

Osteoarthritis (OA)Rheumatoid Arthritis (RA)GoutPseudogout (CPPD Disease)Polymyalgia Rheumatica (PMR)Giant Cell Arteritis (GCA)FibromyalgiaAnkylosing Spondylitis (Axial Spondyloarthritis)Psoriatic Arthritis (PsA)Septic ArthritisOsteomyelitisOsteoporosisAcute Low Back Pain and Lumbar RadiculopathyLumbar Spinal Stenosis

Differentials & related conditions

Antiphospholipid Syndrome (APS)

Educational use only. This outline is a study aid for PA students and is not medical advice or a substitute for clinical judgment. FirstPassPA is an independent study tool and is not affiliated with, endorsed by, or sponsored by NCCPA or PAEA. PANCE® and PANRE® are registered trademarks of the National Commission on Certification of Physician Assistants; End of Rotation™ is a program of the Physician Assistant Education Association.